Enhanced Fluorine-19 MRI Sensitivity using a Cryogenic Radiofrequency Probe: Technical Developments and Ex Vivo Demonstration in a Mouse Model of Neuroinflammation-Reference-Cited by-同舟云学术

Enhanced Fluorine-19 MRI Sensitivity using a Cryogenic Radiofrequency Probe: Technical Developments and Ex Vivo Demonstration in a Mouse Model of Neuroinflammation

Published:2017-08-29 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Waiczies Sonia^ORCID,Millward Jason M.,Starke Ludger,Delgado Paula Ramos,Huelnhagen Till,Prinz Christian^ORCID,Marek Daniel,Wecker Didier,Wissmann Ralph,Koch Stefan P.,Boehm-Sturm Philipp,Waiczies Helmar,Niendorf Thoralf,Pohlmann Andreas

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-09622-2.pdf

Reference52 articles.

1. Stadelmann, C., Wegner, C. & Bruck, W. Inflammation, demyelination, and degeneration-recent insights from MS pathology. Biochim.Biophys.Acta 1812, 275–282 (2011).

2. Lucchinetti, C. et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann.Neurol. 47, 707–717 (2000).

3. Gilmore, C. P. et al. Regional variations in the extent and pattern of grey matter demyelination in multiple sclerosis: a comparison between the cerebral cortex, cerebellar cortex, deep grey matter nuclei and the spinal cord. J. Neurol. Neurosurg. Psychiatry 80, 182–187 (2009).

4. Howell, O. W. et al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134, 2755–2771 (2011).

5. Howell, O. W. et al. Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space. Neuropathol. Appl. Neurobiol. 41, 798–813 (2015).

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifying model uncertainty for semantic segmentation of Fluorine-19 MRI using stochastic gradient MCMC;Computer Vision and Image Understanding;2024-04

2. Delimiting MOGAD as a disease entity using translational imaging;Frontiers in Neurology;2023-12-07

3. How to 19F MRI: applications, technique, and getting started;BJR|Open;2023-08

4. Frontiers in¹⁹F-MR imaging: nanofluorides and¹⁹F-CEST as novel extensions to the¹⁹F-MRI toolbox;Chemical Communications;2023

5. First in vivo fluorine-19 magnetic resonance imaging of the multiple sclerosis drug siponimod;Theranostics;2023